SCHEMBL5899494

SCHEMBL5899494

CCCc1ccc(S(=O)(=O)NCC(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
TSHR P16473 2/20 0.58
MEP1B Q16820 1/20 0.53
POLB P06746 2/20 0.52
LMNA P02545 4/20 0.52
HTT P42858 3/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 1/20 0.49
AKR1C3 P42330 1/20 0.49
KDM4E B2RXH2 1/20 0.49
NPC1 O15118 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899460 0.90 TSHR (0.61) ALDH1A1SMN1; SMN2TSHRMEP1BLMNA
SCHEMBL9777950 0.88 TSHR (0.59) ALDH1A1SMN1; SMN2TSHRMEP1BPOLB
SCHEMBL23014131 0.83 ALDH1A1 (0.57) ALDH1A1TSHRMEP1BCA12CA1
SCHEMBL10592411 0.81 MMP1 (0.55) ALDH1A1SMN1; SMN2POLBLMNAHTT
SCHEMBL23014374 0.81 MEP1B (0.54) ALDH1A1SMN1; SMN2TSHRMEP1BLMNA
SCHEMBL5899469 0.81 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2TSHRMEP1BPOLB
SCHEMBL15580575 0.81 NPC1 (0.59) ALDH1A1SMN1; SMN2LMNAKMT2ANPC1
SCHEMBL10592696 0.80 HTT (0.50) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL10463407 0.77 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2TSHRPOLBLMNA
SCHEMBL11106998 0.77 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2TSHRPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ALDH1A1 139/4885SMN1; SMN2 3869/4885TSHR 3445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.